The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer

British Journal of Cancer

Volumn 110, Issue 7, 2014, Pages 1744-1747

  Downey, C L ^a   Simpkins, S A ^a   White, J ^a   Holliday, D L ^a   Jones, J L ^b   Jordan, L B ^c   Kulka, J ^d   Pollock, S ^a   Rajan, S S ^a   Thygesen, H H ^a   Hanby, A M ^a   Speirs, V ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

breast cancer; male; prognosis; stroma; tumour stroma ratio

Indexed keywords

EOSIN; ESTROGEN RECEPTOR; HEMATOXYLIN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER PROGNOSIS; CANCER SIZE; COMPARATIVE STUDY; FEMALE; FEMALE BREAST CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALE BREAST CANCER; MALE BREAST CARCINOMA; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; STROMA; SURVIVAL RATE; TISSUE SECTION; TUMOR STROMA RATIO;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, ESTROGEN; STROMAL CELLS; SURVIVAL ANALYSIS; TUMOR BURDEN;

EID: 84897570019     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.69     Document Type: Article

References (10)

1. Ahn S, Cho J, Sung J, Lee JE, Nam SJ, Kim K-M, Cho EY (2012) The prognostic significance of tumor-associated stroma in invasive breast carcinoma. Tumour Biol 33(5): 1573-1580.
2. de Kruijf EM, van Nes JGH, van de Velde CJH, Putter H, Smit VTHBM, Liefers GJ, Kuppen PJK, Tollenaar RAEM, Mesker WE (2011) Tumorstroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients. Breast Cancer Res Treat 125(3): 687-696.
3. Dekker TJA, van de Velde CJH, van Pelt GW, Kroep JR, Julien J-P, Smit VTHBM, Tollenaar RAEM, Mesker WE (2013) Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854). Breast Cancer Res Treat 139(2): 371-379.
4. Maeshima AM, Niki T, Maeshima A, Yamada T, Kondo H, Matsuno Y (2002) Modified scar grade. A prognostic indicator in smallperipheral lung adenocarcinoma. Cancer 95: 2546-2554.
5. Mesker WE, Junggeburt JMC, Szuhai K, de Heer P, Morreau H, Tanke HJ, Tollenaar RAEM (2007) The carcinoma-stromal ratio of coloncarcinoma is an independent factor for survival compared to lymphnode status and tumour stage. Cell Oncol 29: 387-398.
6. Moorman AM, Vink R, Heijmans HJ, van der Palen J, Kouwenhoven EA (2012) The prognostic value of tumour-stroma ratio in triple-negative breast cancer. Eur J Surg Oncol 38(4): 307-313.
7. Tchou J, Conejo-Garcia J (2012) Targeting the tumor stroma as a novel treatment strategy for breast cancer: shifting from the neoplastic cell-centric to a stroma-centric paradigm. Adv Pharmacol 65: 45-61.
8. West NP, Dattani M, McShane P, Hutchins G, Grabsch J, Mueller W, Treanor D, Quirke P, Grabsch H (2010) The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. Br J Cancer 102(10): 1519-1523.
9. Wu Y, Grabsch H, Ivanova T, Tan IB, Murray J, Ooi CH, Wright AI, West NP, Hutchins GG, Wu J, Lee M, Lee J, Koo JH, Yeoh KG, van Grieken N, Ylstra B, Rha SY, Ajani JA, Cheong JH, Noh SH, Lim KH, Boussioutas A, Lee JS, Tan P (2013) Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer. Gut 62(8): 1100-1111.
10. Yanagisawa N, Li R, Rowley D, Liu H, Kadmon D, Miles BJ, Wheeler TM, Ayala GE (2007) Stromogenic prostatic carcinoma pattern (carcinomaswith reactive stromal grade 3) in needle biopsies predicts biochemicalrecurrence-free survival in patients after radical prostatectomy. Hum Pathol 38: 1611-1620.